Product Description
Progesterone is an endogenous steroid hormone that is commonly produced by the adrenal cortex as well as the gonads, which consist of the ovaries and the testes. Progesterone is also secreted by the ovarian corpus luteum during the first ten weeks of pregnancy, followed by the placenta in the later phase of pregnancy. (Sourced from: https://www.ncbi.nlm.nih.gov/books/NBK558960/)
Mechanisms of Action: PR Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral,Vaginal,Subcutaneous
FDA Designation: None *
Approval Status: Approved
Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam
Approved Indications: Pregnancy Outcomes | Menopause
Known Adverse Events: Abdominal Pain | Headache | Pain Unspecified | Vaginal Discharge | Constipation | Pelvic Pain | Injuries/wounds Unspecified
Company: IBSA Institut Biochimique
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: Argentina, Austria, Belgium, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Malaysia, Netherlands, Romania, Russia, Singapore, Spain, United Kingdom, United States
Active Clinical Trial Count: 14
Highest Development Phases
Phase 3: Contraception|Infertility|Obstetric Labor, Premature|Traumatic Brain Injury
Phase 1: Healthy Volunteers
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| MR-130A-01-TD-3001 | P3 |
Not yet recruiting |
Contraception |
2027-03-01 |
|
| 2023-504616-15-02 | P3 |
Unknown Status |
Infertility |
2026-12-31 |
|
| 2023-504616-15-00 | P3 |
Unknown Status |
Infertility |
2026-12-31 |
|
| DARE-PTB1-001 | P1 |
Not yet recruiting |
Obstetric Labor, Premature |
2026-01-01 |